Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
fluticasone (cutivate) (1 trial)
formoterol (foradil) (1 trial)
beriplast p (1 trial)
tissucol (1 trial)
tranilast (1 trial)
aflibercept (zaltrap) (1 trial)
cisplatin (platinol) (1 trial)
docetaxel (taxotere) (3 trials)
erlotinib (tarceva) (1 trial)
fluorouracil (efudex) (2 trials)
gemcitabine (gemzar) (2 trials)
leucovorin (2 trials)
oxaliplatin (eloxatin) (2 trials)
panitumumab (vectibix) (1 trial)
vinorelbine (navelbine) (1 trial)
boceprevir (victrelis) (1 trial)
daclatasvir (daklinza) (1 trial)
dasabuvir (Exviera) (1 trial)
elbasvir (1 trial)
grazoprevir (zepatier) (1 trial)
ledipasvir (Harvoni) (1 trial)
ombitasvir (Viekira Pak) (1 trial)
paritaprevir (viekira pak) (1 trial)
ritonavir (Norvir) (1 trial)
simeprevir (olysio) (1 trial)
sofosbuvir (sovaldi) (1 trial)
telaprevir (incivek) (1 trial)
velpatasvir (Epclusa) (1 trial)
Asthma (Phase 4)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Colorectal Neoplasms (Phase 2)
Lung Neoplasms (Phase 2)
Pterygium (Phase 3)
Rectal Neoplasms (Phase 2)
Trials (9 total)
Trial APIs (28 total)